Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components of Innate Immunity to Induce A “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy

15Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

In a T-cell-inflamed phenotype, tumor eradication works best and is potentiated by im-munotherapy such as checkpoint blockade. However, a majority of patients die despite receiving immunotherapy. One reason is insufficient T cell priming and infiltration in the tumor. Nature provides us with innate immune mechanisms in T-cell-inflamed tumors that we can adopt for more personalized immunotherapy strategies. Tumor sensing through innate signaling pathways and ef-ficient antigen-presenting possess a significant role in bridging innate and adaptive immunity and generating a T-cell-inflamed tumor. One approach to strengthen these innate immune mechanisms is to deliver innate immune factors such as STING or activated DCs into the tumor microenviron-ment, in particular in patients resistant to checkpoint blockade. The low number of DCs in the tumor bed could potentially be increased with the growth factor FMS-like tyrosine kinase 3 ligand (Flt3L). CD103+ DCs are integral for three phases of anti-tumor immunity: priming, recruiting, and re-in-vigoration of effector T cells. Re-activation of dysfunctional T cells is achieved via co-stimulatory molecules such as the 4-1BB ligand. The presence of myeloid-cell-derived CXCL9 and CXCL10 in the tumor microenvironment can predict response to immunotherapy. We outline recent preclinical and clinical approaches to deliver these crucial components of innate immunity into the tumor mi-croenvironment.

Cite

CITATION STYLE

APA

Reschke, R., & Olson, D. J. (2022, May 1). Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components of Innate Immunity to Induce A “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cancers14102458

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free